NeilNSenzerMD

Radiation Oncology • Dallas, TX

Physician

Join to view full profile

Are you Dr. Senzer?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 52 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
3410 Worth St
Department Of Radiation Oncology
Dallas, TX 75246
Phone+1 214-370-1400

Fax+1 214-370-1405

Summary

Dr. Neil Senzer, MD is a radiation oncologist in Dallas, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with Baylor University Medical Center and Medical City Dallas.

Education & Training

St Barnabas Medical CenterResidency, Radiation Oncology, 1982 - 1985
University of TennesseeFellowship, Pediatric Hematology/Oncology, 1976 - 1978
Johns Hopkins UniversityResidency, Pediatrics, 1971 - 1974
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1971

Certifications & Licensure

TX State Medical License 1985 - 2018
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

131-I-TM-601 Study in Adults With Solid Tumors Start of enrollment: 2006 Aug 01
Completed
Phase 1
Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer Start of enrollment: 2006 Nov 01
Completed
Phase 1
An Extension Study for Patients Previously Treated With ARQ 501 Start of enrollment: 2006 Dec 01
Completed
Phase 1, Phase 2
A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients Start of enrollment: 2009 May 01
Terminated
Phase 1, Phase 2
Efficacy and Safety Study of Imprime PGG With Cetuximab in Subjects With Stage IV KRAS-Mutated Colorectal Cancer Start of enrollment: 2009 Jun 01
Completed
Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors Start of enrollment: 2010 Oct 01
Completed
Phase 1, Phase 2
A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM ) Start of enrollment: 2011 Dec 29
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

262 citations
Activity of IPI-504, a novel heat-shock protein 90 inhibitor, in patients with molecularly defined non-small-cell lung cancer.
Lecia V. Sequist, Scott N. Gettinger, Neil Senzer, Renato G. Martins, Pasi A. Jänne
Journal of Clinical Oncology. 2010-11-20
448 citations
Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastati...
Neil Senzer, Howard L. Kaufman, Thomas Amatruda, Mike Nemunaitis, Tony Reid
Journal of Clinical Oncology. 2009-12-01
77 citations
A Phase I Dose-Escalation Study of Tivantinib (ARQ 197) in Adult Patients with Metastatic Solid Tumors
Lee S. Rosen, Neil Senzer, Tarek Mekhail, Ram Ganapathi, Feng Chai
Clinical Cancer Research. 2011-12-15